Steve Pet is an associate in the Washington, DC office of Gibson, Dunn & Crutcher and a member of the firm’s Antitrust and Competition Practice Group.

He advises clients on all aspects of antitrust law, with a focus on merger and non-merger investigations before the Federal Trade Commission and the Department of Justice, antitrust counseling, and complex private and government antitrust litigation. His antitrust experience spans a wide range of industries, including healthcare and pharmaceuticals, energy, transportation, and technology.

Steve currently serves as Vice Chair of the ABA Antitrust Section’s Agriculture and Food Committee.  Before law school, he was an Honors Paralegal at the Federal Trade Commission’s Bureau of Competition, where he spent time working at the staff level and in the Bureau Director’s Office. Among other matters, Steve was actively involved in the FTC’s successful challenge to the proposed $3.5 billion merger of Sysco and U.S. Foods.

He received his law degree from the University of Virginia School of Law, where he graduated Order of the Coif and served on the Editorial Board of the Virginia Law Review. Steve earned a Bachelor of Arts degree summa cum laude from Hamilton College.

Representative matters include*

• Represented Celgene in the FTC’s conditional approval of its $74 billion acquisition by Bristol-Myers Squibb
• Represented Arch Coal in proposed joint venture with Peabody Energy from initial investigation through Section Request and litigation against the FTC (E.D. Mo.)
• Represented shipping provider during extensive DOJ investigation of proposed acquisition of another shipping provider, securing unconditional clearance
• Represented third party before the FTC in successfully opposing proposed transaction in life sciences industry
• Represented large technology company in FTC study on non-reportable acquisitions
• Represented large generic pharmaceutical manufacturers in multi-district litigation and related criminal antitrust investigation (E.D. Pa.)
• Represented large branded pharmaceutical company in State Attorney General investigation of patent settlement with another large pharmaceutical company
• Represented Ribbon Communications against claims alleging violations of Sherman Act Sections 1 & 2, Lanham Act, and various state law claims (S.D.N.Y.)

*Includes matters handled prior to joining Gibson Dunn

Steve is admitted to practice in the District of Columbia.